MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in MoonLake Immunotherapeutics as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 111
- −1 vs. Q1 2024
- Shares held
- 60.8M
- +1.32M (+2.2%) vs. Q1 2024
- Total value
- $2.67B
- −$314.3M (−10.5%) vs. Q1 2024
- New holders
- 22
- 36 more added
- Sold out
- 23
- 39 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtus ETF Advisers LLC | 2,120 | $93.2K | 0.05% | +616+41.0% | Added |
| Simplex Trading, LLC | 2,118 | $93.0K | 0.00% | +2,118 | New |
| Deutsche Bank AG | 565 | $24.8K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 412 | $18.1K | 0.00% | −3,367−89.1% | Reduced |
| New York State Common Retirement Fund | 140 | $6.16K | 0.00% | −8,126−98.3% | Reduced |
| Private Trust Co NA | 122 | $5.36K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $4.40K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 75 | $3.30K | 0.00% | −25−25.0% | Reduced |
| Tower Research Capital LLC (TRC) | 47 | $2.07K | 0.00% | −232−83.2% | Reduced |
| Planning Capital Management Corp | 2 | $88 | 0.00% | +2 | New |
| CWM, LLC | 5 | $0 | 0.00% | +5 | New |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −1,095,101−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −339,012−100.0% | Sold out |
| Blue Owl Capital Holdings LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −90,647−100.0% | Sold out |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 0 | $0 | 0.00% | −87,500−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −86,487−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −31,941−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −26,713−100.0% | Sold out |
| Resolute Capital Asset Partners LLC | 0 | $0 | 0.00% | −24,541−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −14,458−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −12,332−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −9,697−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −7,780−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −7,696−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −5,858−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −5,655−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −4,942−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −4,800−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −4,149−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −4,002−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −862−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −565−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Cutler Group LP | – | – | – | – | Not filed |